Waltermire Robert E.'s Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Dec 14, 2023
- Accession no.
- 0000950170-23-070416
- Filed
- Dec 14, 2023
- Trade date
- Dec 12-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $846.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Waltermire Robert E.CIK 0001876996 | Officer (Senior VP, Chief Pharma Dev.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Common Stock | MOption exerciseAcquired | +1,300 | $87.92 | +$114,296 | 6,967 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −500 | $216.00 | −$108,000 | 6,467 | Direct | |
| Dec 12, 2023 | Common Stock | SSaleDisposed | −800 | $219.00 | −$175,200 | 5,667 | Direct | |
| Dec 13, 2023 | Common Stock | MOption exerciseAcquired | +2,500 | $87.92 | +$219,800 | 8,167 | Direct | |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −1,500 | $225.00 | −$337,500 | 6,667 | Direct | |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −1,000 | $226.00 | −$226,000 | 5,667 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Common Stock | MOption exerciseDisposed | −1,300 | $0.00 | $0 | 23,700 | Direct | |
| Dec 13, 2023 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 21,200 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
*As attorney-in-fact for Reporting Person